Literature DB >> 20178321

Discovery and SAR of thiazolidine-2,4-dione analogues as insulin-like growth factor-1 receptor (IGF-1R) inhibitors via hierarchical virtual screening.

Xiaofeng Liu1, Hua Xie, Cheng Luo, Linjiang Tong, Yi Wang, Ting Peng, Jian Ding, Hualiang Jiang, Honglin Li.   

Abstract

Insulin-like growth factor-1 receptor (IGF-1R) is a growth factor receptor tyrosine kinase acting as a critical mediator of cell proliferation and survival. Novel 5-benzylidenethiazolidine-2,4-dione (5) and 5-(furan-2-ylmethylene)thiazolidine-2,4-dione (6) compounds were identified as potent and selective IGF-1R inhibitors via hierarchical virtual screening. Initial SAR and biological activity of the analogues of 5 and 6 with thiazolidine-2,4-dione template are presented, and several inhibitors with low nanomolar potency are reported.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20178321     DOI: 10.1021/jm901798e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

Review 1.  Computational drug discovery.

Authors:  Si-Sheng Ou-Yang; Jun-Yan Lu; Xiang-Qian Kong; Zhong-Jie Liang; Cheng Luo; Hualiang Jiang
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

2.  Establishment of platform for screening insulin-like growth factor-1 receptor inhibitors and evaluation of novel inhibitors.

Authors:  Lin-jiang Tong; Hua Xie; Ting Peng; Xiao-feng Liu; Xian-liang Xin; Xun Huang; Si-meng Chen; Hong-yan Liu; Hong-lin Li; Mei-yu Geng; Ming Yin; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2011-06-06       Impact factor: 6.150

3.  Pleiotropic effects of glitazones: a double edge sword?

Authors:  Salvatore Salomone
Journal:  Front Pharmacol       Date:  2011-03-18       Impact factor: 5.810

4.  AST1306, a novel irreversible inhibitor of the epidermal growth factor receptor 1 and 2, exhibits antitumor activity both in vitro and in vivo.

Authors:  Hua Xie; Liping Lin; Linjiang Tong; Yong Jiang; Mingyue Zheng; Zhuo Chen; Xiaoyan Jiang; Xiaowei Zhang; Xiaowei Ren; Wenchao Qu; Yang Yang; Hua Wan; Yi Chen; Jianping Zuo; Hualiang Jiang; Meiyu Geng; Jian Ding
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

5.  IVSPlat 1.0: an integrated virtual screening platform with a molecular graphical interface.

Authors:  Yin Xue Sun; Yan Xin Huang; Feng Li Li; Hong Yan Wang; Cong Fan; Yong Li Bao; Lu Guo Sun; Zhi Qiang Ma; Jun Kong; Yu Xin Li
Journal:  Chem Cent J       Date:  2012-01-05       Impact factor: 4.215

6.  iDrug: a web-accessible and interactive drug discovery and design platform.

Authors:  Xia Wang; Haipeng Chen; Feng Yang; Jiayu Gong; Shiliang Li; Jianfeng Pei; Xiaofeng Liu; Hualiang Jiang; Luhua Lai; Honglin Li
Journal:  J Cheminform       Date:  2014-05-23       Impact factor: 5.514

7.  Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores.

Authors:  Nathalie Lagarde; Solenne Delahaye; Jean-François Zagury; Matthieu Montes
Journal:  J Cheminform       Date:  2016-09-06       Impact factor: 5.514

8.  Synthesis and antibacterial activity of new (2,4-dioxothiazolidin-5-yl/ylidene)acetic acid derivatives with thiazolidine-2,4-dione, rhodanine and 2-thiohydantoin moieties.

Authors:  Nazar Trotsko; Urszula Kosikowska; Agata Paneth; Monika Wujec; Anna Malm
Journal:  Saudi Pharm J       Date:  2018-02-02       Impact factor: 4.330

Review 9.  Application of computational methods for anticancer drug discovery, design, and optimization.

Authors:  Diego Prada-Gracia; Sara Huerta-Yépez; Liliana M Moreno-Vargas
Journal:  Bol Med Hosp Infant Mex       Date:  2016-11-30

10.  Virtual screening of specific insulin-like growth factor 1 receptor (IGF1R) inhibitors from the National Cancer Institute (NCI) molecular database.

Authors:  Cong Fan; Yan-Xin Huang; Yong-Li Bao; Lu-Guo Sun; Yin Wu; Chun-Lei Yu; Yu Zhang; Zhen-Bo Song; Li-Hua Zheng; Ying Sun; Guan-Nan Wang; Yu-Xin Li
Journal:  Int J Mol Sci       Date:  2012-12-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.